Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;42(4):1377-1387.
doi: 10.1007/s10072-021-05099-0. Epub 2021 Feb 5.

The links between diabetes mellitus and amyotrophic lateral sclerosis

Affiliations
Review

The links between diabetes mellitus and amyotrophic lateral sclerosis

Rosario Vasta et al. Neurol Sci. 2021 Apr.

Abstract

ALS etiology and prognostic factors are mostly unknown. Metabolic diseases and especially diabetes mellitus (DM) have been variously related to ALS. However, pieces of evidence have been variegated and often conflicting so far. This review aims to give an overview of recent contributions focusing on the relationship between DM and ALS. DM seems to reduce the risk of developing ALS if diagnosed at a younger age; conversely, when diagnosed at an older age, DM seems protective against ALS. Such a relationship was not confirmed in Asian countries where DM increases the risk of ALS independently of the age of onset. Interestingly, DM does not affect ALS prognosis, possibly weakening the potential causal relationship between the two diseases. However, since most studies are observational, it is difficult to state the exact nature of such a relationship and several hypotheses have been made. A recent study using Mendelian randomization suggested that DM is indeed protective against ALS in the European population. However, these analyses are not without limits and further evidence is needed. DM is usually the core of a larger metabolic syndrome. Thus, other metabolic changes such as dyslipidemia, body mass index, and cardiovascular diseases should be collectively considered. Finally, hypermetabolism usually found in ALS patients should be considered too since all these metabolic changes could be compensation (or the cause) of the higher energy expenditure.

Keywords: Amyotrophic lateral sclerosis; Diabetes mellitus; Epidemiology; Metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

Rosario Vasta, Fabrizio d’Ovidio: no disclosures. Giancarlo Logroscino is associated editor of the Neuroepidemiology journal (Karger, Basel). He has received support from: (1) Regione Puglia (DGR n. 1284 - 27.05.2015) for the project “Registro Regionale per la SLA, la FTD-P e le patologie affini in Regione Puglia (SLAPDem register- www.slapdem.it) and from Italian Ministry of Health (Ricerca Corrente); (2) Regione Puglia and Consiglio Nazionale delle Ricerche (CNR) for Tecnomed Puglia for Precision Medicine D.G.R. n. 2117 of 21.11.2018. Adriano Chiò serves on the editorial advisory board of Amyotrophic Lateral Sclerosis and Neurological Sciences and has received research support from the Italian Ministry of Health (Ricerca Finalizzata), Regione Piemonte (Ricerca Finalizzata), University of Turin, and the European Commission (Health Seventh Framework Programme), and serves on scientific advisory boards for Biogen Idec, Cytokinetics, and Avexis.

References

    1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet Lond Engl. 2011;377:942–955. doi: 10.1016/S0140-6736(10)61156-7. - DOI - PubMed
    1. Ingre C, Roos PM, Piehl F, et al. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–193. doi: 10.2147/CLEP.S37505. - DOI - PMC - PubMed
    1. (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36:S67–S74. 10.2337/dc13-S067 - PMC - PubMed
    1. WHO | Global report on diabetes. In: WHO. http://www.who.int/diabetes/publications/grd-2016/en/. Accessed 16 Jan 2020
    1. Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75–82. doi: 10.1016/S1474-4422(10)70224-6. - DOI - PubMed